Large-scale testing (Phase 3)Study completedNCT01492361
What this trial is testing
AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin
Who this might be right for
Cardiovascular Diseases
Amarin Pharma Inc. 8,179